The distribution company, based in Taipei, currently employs approximately 45 individuals and has represented and distributed Varian equipment for more than 40 years, the Palo Alto, Calif.-based company said.
“With the acquisition of COOP, Varian will be able to work and collaborate more closely with our customers in Taiwan as well as providing more efficient and comprehensive services,” Varian Asia Pacific prez Kevin O’Reilly said in a prepared release.
“COOP has built a strong team in Taiwan. The team, led by Christina Lin as the new managing director of Varian Taiwan, is now able to directly access all Varian resources and tools for products and services. We hope to provide enhanced service for our customers and expand the access of quality and cost-effective cancer care solutions in Taiwan, as well as engage in more clinical research and collaborations with leading hospitals,” Varian regional manging director Xiao Zhang said in a press release.
“Since its founding, COOP has been focused on being the best partner for clinicians in the fight against cancer. We are committed to providing the most advanced solutions and comprehensive services for customers in Taiwan to save more lives. I believe by joining the Varian family and leveraging its global network, we can better serve customers in Taiwan and provide state-of-the-art cancer care for patients in Taiwan,” COOP founder CP Lin said in a prepared statement.
Late last month, Varian saw shares rise slightly after the medical device maker posted fiscal year 2018 second quarter earnings that beat The Street and saw profits and sales grow.
These featured panels at DeviceTalks Boston will explore the state of R&D at major medtech firms, as well as the latest trends when it comes to developing combination products, neuromodulation devices, robotic systems and women's health technology.
View Technology Track Featured Sessions
Register today to save. Use code TECHTRACK to save an additional 10%.